Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis

Concentrations of circulating galectin-3, a metastasis promoter, are greatly increased in cancer patients. Here we show that 2- or 6-de-O-sulfated, N-acetylated heparin derivatives are galectin-3 binding inhibitors. These chemically modified heparin derivatives inhibited galectin-3-ligand binding an...

Descripción completa

Detalles Bibliográficos
Autores principales: Duckworth, Carrie A., Guimond, Scott E., Sindrewicz, Paulina, Hughes, Ashley J., French, Neil S., Lian, Lu-Yun, Yates, Edwin A., Pritchard, D. Mark, Rhodes, Jonathan M., Turnbull, Jeremy E., Yu, Lu-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695144/
https://www.ncbi.nlm.nih.gov/pubmed/26160844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695144/
https://www.ncbi.nlm.nih.gov/pubmed/26160844

Ejemplares similares